AlphaLogix announces market release of AlphaFlo® canine allograft

4

Back to all posts

Press Release

AlphaLogix announces market release of AlphaFlo^® canine allograft

Equus Innovations, a manufacturer of advanced, next-generation veterinary regenerative products, in partnership with AlphaLogix, LLC (Argyle, Texas) announced today successful market release of a new canine allograft, AlphaFlo^®.

Read the Press Release

You may want to read these articles

Cryopreserved Liquid Amnion Product vs. Powder (Lyophilized) Amnion Product

Amniotic tissue contains naturally occurring elements such as growth factors, cytokines, extracellular matrix proteins, and exosomes. These components are intrinsic to the native structure of the amniotic membrane and fluid and may be beneficial in supporting tissue...

Rethinking Equine Stifle Injuries: Surprising Insights from a New Study

August 11, 2020: A horse presented to The Equine Performance Center, Ocala, FL, with bilateral corneal ulcers. Following eye examination, sub-palpebral lavage was placed in both eyes and IV catheter was placed. The horse received aggressive medical therapy including...

RenoVō^® CASE STUDY: Puncture Wound

Case presentation - June 9, 2022: A three-year-old Quarter Horse filly backed into the catch for the stall door and punctured herself, creating a large, deep wound on her left thigh. The wound was sutured with internal and external stiches at clinic, however the...

Back to all posts

Cryopreserved Liquid Amnion Product vs. Powder (Lyophilized) Amnion Product

Rethinking Equine Stifle Injuries: Surprising Insights from a New Study

RenoVō® CASE STUDY: Puncture Wound

RenoVō^® CASE STUDY: Puncture Wound